132 related articles for article (PubMed ID: 10894090)
21. Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells.
Yamamoto C; Kaji T; Sakamoto M; Kozuka H; Koizumi F
Thromb Res; 1994 Apr; 74(2):163-8. PubMed ID: 8029817
[TBL] [Abstract][Full Text] [Related]
22. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand.
Cheng XF; Bäck O; Nilsson TK; Nylander Lundqvist E; Pohl G; Wallén P
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):407-13. PubMed ID: 1332673
[TBL] [Abstract][Full Text] [Related]
23. The role of plasminogen activator inhibitor type 1 in the clearance of tissue-type plasminogen activator by rat hepatoma cells.
Camani C; Bachmann F; Kruithof EK
J Biol Chem; 1994 Feb; 269(8):5770-5. PubMed ID: 8119917
[TBL] [Abstract][Full Text] [Related]
24. Binding of recombinant variants of human tissue-type plasminogen activator (t-PA) to human umbilical vein endothelial cells.
Stockinger H; Kubbies M; Rudolph R; Stern A; Kohnert U; Fischer S
Thromb Res; 1992 Sep; 67(5):589-99. PubMed ID: 1333104
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
Korner G; Bjornsson TD; Vlodavsky I
J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression.
Zhang WJ; Wojta J; Binder BR
J Vasc Res; 1997; 34(4):273-80. PubMed ID: 9256087
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
Lijnen HR; De Cock F; Collen D
Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
[TBL] [Abstract][Full Text] [Related]
28. Determinants of induction of increased synthesis of plasminogen activator inhibitor type-1 in human endothelial cells by t-PA.
Fujii S; Sobel BE
Thromb Haemost; 1992 Feb; 67(2):233-8. PubMed ID: 1621243
[TBL] [Abstract][Full Text] [Related]
29. Biochemical and functional characterization of human tissue-type plasminogen activator variants obtained by deletion and/or duplication of structural/functional domains.
Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
J Biol Chem; 1990 Apr; 265(10):5677-83. PubMed ID: 2156824
[TBL] [Abstract][Full Text] [Related]
30. Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions.
Kuiper J; Van't Hof A; Otter M; Biessen EA; Rijken DC; van Berkel TJ
Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):775-80. PubMed ID: 8611154
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
[TBL] [Abstract][Full Text] [Related]
32. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
[TBL] [Abstract][Full Text] [Related]
33. Kinetic characterization of tissue-type plasminogen activator (t-PA) and t-PA deletion mutants.
de Vries C; Veerman H; Nesheim ME; Pannekoek H
Thromb Haemost; 1991 Mar; 65(3):280-5. PubMed ID: 1904654
[TBL] [Abstract][Full Text] [Related]
34. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activator.
Bartha K; Declerck PJ; Moreau H; Nelles L; Collen D
J Biol Chem; 1991 Jan; 266(2):792-7. PubMed ID: 1898737
[TBL] [Abstract][Full Text] [Related]
36. Effects of fibrin on the secretion of plasminogen activator inhibitor-1 from endothelial cells and on protein kinase C.
Fukao H; Matsumoto H; Ueshima S; Okada K; Matsuo O
Life Sci; 1995; 57(13):1267-76. PubMed ID: 7674818
[TBL] [Abstract][Full Text] [Related]
37. Regulatory effects of estetrol on the endothelial plasminogen pathway and endothelial cell migration.
Montt-Guevara MM; Palla G; Spina S; Bernacchi G; Cecchi E; Campelo AE; Shortrede JE; Canu A; Simoncini T
Maturitas; 2017 May; 99():1-9. PubMed ID: 28364860
[TBL] [Abstract][Full Text] [Related]
38. Tissue-type plasminogen activator binding to human endothelial cells. Evidence for two distinct binding sites.
Barnathan ES; Kuo A; Van der Keyl H; McCrae KR; Larsen GR; Cines DB
J Biol Chem; 1988 Jun; 263(16):7792-9. PubMed ID: 3131327
[TBL] [Abstract][Full Text] [Related]
39. [Expression and activity of tissue-type plasminogen activator mutant reteplase with deletion of PAI-1 binding sites].
Zhu MC; Zhan Z; Wang YJ; Liu CG; Shi Y; Cai Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):565-9. PubMed ID: 16143058
[TBL] [Abstract][Full Text] [Related]
40. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
Mussoni L; Banfi C; Sironi L; Arpaia M; Tremoli E
Thromb Haemost; 2000 Jul; 84(1):59-64. PubMed ID: 10928471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]